Sharmon P. Osae

Sharmon P. Osae

Auto-generated profile, based on publicly available information

Sharmon P. Osae

University of Georgia College of Pharmacy

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2022 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Closed access
PDF file
SOSharmon P. Osae
Sharmon P. Osae
DCDaniel B. Chastain
Daniel B. Chastain
HYHenry N. Young
Henry N. Young

10 November 2021 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Closed access
PDF file
SOSharmon P. Osae
Sharmon P. Osae
DCDaniel Chastain
Daniel Chastain
HYHenry N. Young
Henry N. Young

23 October 2019 in Journal of Pharmacy Practice
Verified
Journal Article
Closed access
PDF file
SOSharmon P. Osae
Sharmon P. Osae
ARAlaina Rotelli
Alaina Rotelli
Objective: To summarize findings of pharmacist involvement with Medicare Annual Wellness Visits (AWV), including the number of pharmacist interventions, patient/provider satisfaction, and billing models. Data Sources: A literature search was conducted using PubMed, ScienceDirect College Edition Journals Collection-Health and Life Sciences, Cochrane Library, CINAHL, Medline, and Academic Search Complete, including dates between January 01, 2011, and November 05, 2018. Study Selection: Search was limited to full-text, peer-reviewed articles, published in English which were relevant based on identification of a pharmacist’s role in AWV. Search terms included “Medicare annual wellness visits” and “Pharmacists.” Data Extraction: A data extraction tool was used to collect study authors, year published, study design, description of intervention, objectives, primary outcome measures, model of care, clinic setting, location, results, number of patients, and overall effect. Results: Of the 139 returned citations, 11 met inclusion criteria. Of the practice settings, 7 (72.72%) utilized a collaborative practice agreement for conducting AWV. Six (54.54%) of the studies measured financial outcomes, 3 (27.27%) measured satisfaction of students/patients/physicians, 2 (18.18%) measured clinical outcomes, and finally 4 (36.36%) measured number and types of interventions. Review revealed that 6 (54.54%) articles had more medication-related interventions than nonmedication-related interventions. Studies evaluating finances as it relates to AWVs had various findings including 38% return on investment, higher reimbursement for pharmacist-led visits, and an increase in revenue. Conclusion: In a variety of outpatient health centers, AWV were conducted by pharmacists, had a positive impact on patient care, and had high satisfaction rates between patients and physicians.

5 June 2020 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
DCDaniel Chastain
Daniel Chastain
TSTia M Stitt
Tia M Stitt
PLPhong T Ly
Phong T Ly
Andrés Henao-MartinezAndrés Henao-Martinez
Andrés Henao-Martinez
Carlos Franco-ParedesCarlos Franco-Paredes
Carlos Franco-Paredes
SOSharmon P Osae
Sharmon P Osae
Severe acute respiratory syndrome coronavirus 2 is associated with higher concentrations of proinflammatory cytokines that lead to lung damage, respiratory failure, and resultant increased mortality. Immunomodulatory therapy has the potential to inhibit cytokines and quell the immune dysregulation. Controversial data found improved oxygenation after treatment with tocilizumab, an interleukin-6 inhibitor, sparking a wave of interest and resultant clinical trials evaluating immunomodulatory therapies. The purpose of this article is to assess potential proinflammatory targets and review the safety and efficacy of immunomodulatory therapies in managing patients with acute respiratory distress syndrome associated with coronavirus disease 2019.

24 August 2023 in Journal of the American Pharmacists Association
Verified
Journal Article
Closed access
Smita RawalSmita Rawal
Smita Rawal
SOSharmon P. Osae
Sharmon P. Osae
RTRandall L. Tackett
Randall L. Tackett
Neil MacKinnonNeil MacKinnon
Neil MacKinnon
FSFrantz D. Soiro
Frantz D. Soiro
HYHenry N. Young
Henry N. Young

3 July 2024 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Open access
IHIla M. Harris
Ila M. Harris
MHMichelle L. Hilaire
Michelle L. Hilaire
MJMichelle Jeon
Michelle Jeon
KKKAREN L KIER
KAREN L KIER
FMFaria M. Munir
Faria M. Munir
SOSharmon P. Osae
Sharmon P. Osae
Medical misinformation can pose serious threats to public health. This commentary explores the pharmacist's unique role in addressing and mitigating the impact of medical misinformation. Pharmacists are uniquely positioned to engage with other healthcare providers, patients, and communities to dispel myths, provide accurate information, and promote evidence‐based healthcare decision‐making. This commentary showcases examples of the multifaceted roles of pharmacists in combating medical misinformation. It explores various strategies and interventions that can be used by pharmacists, including patient education, effective communication, information dissemination, and community engagement. Pharmacists' interventions are often at the intersection of medication management and health information needs, making them integral in ensuring patients and providers make informed healthcare choices. Moreover, this commentary highlights the impact pharmacists can have as advocates for scientific rigor and evidence‐based practices within healthcare systems to educate against medical misinformation and discusses the need for continued education, training, and support for pharmacists to excel in their roles as healthcare educators and medication experts. Pharmacists have a role in countering medical misinformation when serving patients by providing information that empowers a more informed society.